methazolamide has been researched along with Drug-Induced Stevens Johnson Syndrome in 16 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are life-threatening adverse drug reactions." | 9.01 | Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis. ( Lohitnavy, M; Tangamornsuksan, W, 2019) |
| "The carbonic anhydrase inhibitor methazolamide infrequently causes Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)." | 7.76 | HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. ( Jee, YK; Kang, HR; Kim, M; Kim, SH; Lee, KW; Park, HW, 2010) |
| "Four cases of Stevens-Johnson syndrome considered to be induced by methazolamide were reported." | 7.69 | Stevens-Johnson syndrome induced by methazolamide treatment. ( Joukou, S; Kagaya, F; Shirato, S; Suzuki, Y, 1997) |
| "Methazolamide is an intraocular pressure-lowering drug that is used in the treatment of glaucoma and other ophthalmologic abnormalities." | 5.43 | HLA-B*59:01: a marker for Stevens-Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese. ( Cao, Z; Chen, J; Chen, S; He, L; Luo, H; Luo, X; Sun, X; Xing, Q; Xuan, J; Yang, F; Zhong, H; Zhou, P, 2016) |
| "Methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are life-threatening adverse drug reactions." | 5.01 | Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis. ( Lohitnavy, M; Tangamornsuksan, W, 2019) |
| " Methazolamide, an anti-glaucomatous agent, could cause severe skin eruptions called Stevens-Johnson syndrome/toxic epidermal necrolyis (SJS/TEN)." | 3.85 | The Metabolism of Methazolamide in Immortalized Human Keratinocytes, HaCaT Cells. ( Kishida, K; Maeda, S; Miwa, Y; Sasabe, T; Sugiyama, T; Yamano, M, 2017) |
| "Methazolamide is used to lower intraocular pressure in patients with glaucoma." | 3.81 | Toxic epidermal necrolysis induced by methazolamide in a Chinese-Korean man carrying HLA-B*59:01. ( Dong, Q; Mao, X; Shu, C; Shu, D; Sun, Q; Tie, D; Wang, T; Yan, Y; Yu, M; Zhang, R, 2015) |
| "The carbonic anhydrase inhibitor methazolamide infrequently causes Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)." | 3.76 | HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. ( Jee, YK; Kang, HR; Kim, M; Kim, SH; Lee, KW; Park, HW, 2010) |
| "Four cases of Stevens-Johnson syndrome considered to be induced by methazolamide were reported." | 3.69 | Stevens-Johnson syndrome induced by methazolamide treatment. ( Joukou, S; Kagaya, F; Shirato, S; Suzuki, Y, 1997) |
| "Stevens-Johnson syndrome (SJS) /toxic epidermal necrolysis (TEN) are life-threatening severe cutaneous adverse drug reactions characterized by widespread epidermal necrosis." | 2.90 | Comprehensive assessment of T cell receptor β repertoire in Stevens-Johnson syndrome/toxic epidermal necrolysis patients using high-throughput sequencing. ( Chen, S; Jiang, M; Luo, X; Qin, S; Tang, C; Wang, L; Xing, Q; Xiong, H; Yang, F; Zhu, H; Zhu, Q, 2019) |
| "Methazolamide is an intraocular pressure-lowering drug that is used in the treatment of glaucoma and other ophthalmologic abnormalities." | 1.43 | HLA-B*59:01: a marker for Stevens-Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese. ( Cao, Z; Chen, J; Chen, S; He, L; Luo, H; Luo, X; Sun, X; Xing, Q; Xuan, J; Yang, F; Zhong, H; Zhou, P, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, PW | 1 |
| Chu, CY | 1 |
| Qiumei, G | 1 |
| Zhengju, C | 1 |
| Xuefei, H | 1 |
| Qu, C | 1 |
| Sohn, KH | 1 |
| Kim, SH | 4 |
| Kang, HR | 2 |
| Shi, L | 1 |
| Li, M | 1 |
| Zhang, F | 1 |
| Wang, B | 1 |
| Yi, X | 1 |
| Ding, Y | 1 |
| Wang, X | 1 |
| Jiang, YY | 1 |
| Nguyen, GH | 1 |
| Jin, HZ | 1 |
| Zeng, YP | 1 |
| Tangamornsuksan, W | 1 |
| Lohitnavy, M | 1 |
| Xiong, H | 1 |
| Wang, L | 1 |
| Jiang, M | 1 |
| Chen, S | 2 |
| Yang, F | 2 |
| Zhu, H | 1 |
| Zhu, Q | 1 |
| Tang, C | 1 |
| Qin, S | 1 |
| Xing, Q | 2 |
| Luo, X | 2 |
| Xuan, J | 1 |
| Chen, J | 1 |
| Zhong, H | 1 |
| Luo, H | 1 |
| Zhou, P | 1 |
| Sun, X | 1 |
| He, L | 1 |
| Cao, Z | 1 |
| Shu, C | 1 |
| Shu, D | 1 |
| Tie, D | 1 |
| Yu, M | 1 |
| Zhang, R | 1 |
| Wang, T | 1 |
| Dong, Q | 1 |
| Sun, Q | 2 |
| Mao, X | 1 |
| Yan, Y | 1 |
| Xu, Y | 1 |
| Wu, M | 1 |
| Sheng, F | 1 |
| Sasabe, T | 1 |
| Maeda, S | 1 |
| Kishida, K | 1 |
| Yamano, M | 1 |
| Miwa, Y | 1 |
| Sugiyama, T | 1 |
| Jee, YK | 2 |
| Kim, S | 1 |
| Lee, JM | 1 |
| Park, HS | 1 |
| Kim, M | 1 |
| Lee, KW | 1 |
| Park, HW | 1 |
| Flach, AJ | 1 |
| Smith, RE | 1 |
| Fraunfelder, FT | 1 |
| Shirato, S | 1 |
| Kagaya, F | 1 |
| Suzuki, Y | 1 |
| Joukou, S | 1 |
| Cotter, JB | 1 |
1 review available for methazolamide and Drug-Induced Stevens Johnson Syndrome
| Article | Year |
|---|---|
Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis.
Topics: Asian People; Drug Hypersensitivity Syndrome; Genetic Predisposition to Disease; Genotype; HLA-B Ant | 2019 |
1 trial available for methazolamide and Drug-Induced Stevens Johnson Syndrome
| Article | Year |
|---|---|
Comprehensive assessment of T cell receptor β repertoire in Stevens-Johnson syndrome/toxic epidermal necrolysis patients using high-throughput sequencing.
Topics: Allopurinol; Carbamazepine; Female; High-Throughput Nucleotide Sequencing; Humans; Male; Methazolami | 2019 |
14 other studies available for methazolamide and Drug-Induced Stevens Johnson Syndrome
| Article | Year |
|---|---|
Genetic markers for methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
Topics: Case-Control Studies; Genetic Markers; Humans; Methazolamide; Stevens-Johnson Syndrome | 2022 |
Association of HLA-C*01:02 with methazolamide-induced toxic epidermal necrolysis.
Topics: Ethnicity; Female; HLA-B Antigens; HLA-C Antigens; Humans; Methazolamide; Minority Groups; Stevens-J | 2022 |
Cross-Reactivity Between Carbonic Anhydrase Inhibitor Confirmed by Lymphocyte Transformation Test: A Case of Methazolamide-Induced Toxic Epidermal Necrolysis.
Topics: Carbonic Anhydrase Inhibitors; Humans; Lymphocyte Activation; Methazolamide; Stevens-Johnson Syndrom | 2021 |
A rare case of topical methazolamide ophthalmic solution causing death due to toxic epidermal necrolysis.
Topics: Administration, Topical; Aged; Carbonic Anhydrase Inhibitors; Fatal Outcome; Fever; Humans; Male; Me | 2018 |
Methazolamide-induced toxic epidermal necrolysis in a man carrying HLA-B*59:01: successful treatment with infliximab and glucocorticoid.
Topics: Adult; Asian People; China; Drug Therapy, Combination; Glaucoma; Glucocorticoids; HLA-B Antigens; Hu | 2018 |
HLA-B*59:01: a marker for Stevens-Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese.
Topics: Adult; Aged; Asian People; Carbonic Anhydrase Inhibitors; Case-Control Studies; Female; Genetic Asso | 2016 |
Toxic epidermal necrolysis induced by methazolamide in a Chinese-Korean man carrying HLA-B*59:01.
Topics: Adult; Alleles; Asian People; Carbonic Anhydrase Inhibitors; China; Genotype; Glaucoma; HLA-B Antige | 2015 |
Methazolamide-induced toxic epidermal necrolysis in a Chinese woman with HLA-B5901.
Topics: Carbonic Anhydrase Inhibitors; China; Female; Glaucoma; Glucocorticoids; HLA-B Antigens; Humans; Inj | 2015 |
The Metabolism of Methazolamide in Immortalized Human Keratinocytes, HaCaT Cells.
Topics: Acetylcysteine; beta-Naphthoflavone; Carbonic Anhydrase Inhibitors; Cell Line; Chromatography, High | 2017 |
CD8
Topics: Autoantibodies; CD8-Positive T-Lymphocytes; Disease Susceptibility; Genotype; HLA Antigens; Humans; | 2017 |
HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Topics: Adult; Alleles; Female; Genotype; HLA-B Antigens; Humans; Male; Methazolamide; Middle Aged; Republic | 2010 |
Stevens-Johnson syndrome associated with methazolamide treatment reported in two Japanese-American women.
Topics: Adult; Aged; Carbonic Anhydrase Inhibitors; Eye Diseases; Female; Follow-Up Studies; Humans; Japan; | 1995 |
Stevens-Johnson syndrome induced by methazolamide treatment.
Topics: Adult; Carbonic Anhydrase Inhibitors; Corneal Diseases; Corneal Transplantation; Female; Glaucoma; H | 1997 |
Methazolamide-induced Stevens-Johnson syndrome: a warning!
Topics: Carbonic Anhydrase Inhibitors; Female; Humans; Intraocular Pressure; Methazolamide; Middle Aged; Ocu | 1998 |